NASDAQ · SILO
Silo Pharma, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for SILO: Nov 12, 2026
Silo Pharma, Inc. Common Stock is estimated to report earnings on 11/12/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-1.8.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · MarketBeat- RTTNews · Sep 18, 3:27 PM EDTBiotech Stocks In Focus – IMCC +245%, XRTX +12%, SILO, BFRI(RTTNews) – The following biotech and healthcare stocks were in focus on Friday following significant share-price moves and company updates.
- RTTNews · Sep 18, 9:04 AM EDTSilo Pharma Gets U.S. Patent Allowance For SPC-15 PTSD Treatment(RTTNews) – Silo Pharma, Inc. (SILO) announced that the U.S. Patent and Trademark Office (USPTO) issued a Notice of Allowance for a patent application covering SPC-15, the company's investigational intranasal therapeutic being developed for post-traumatic stress disorder (PTSD).
- RTTNews · Sep 9, 11:28 AM EDTSilo Pharma To Highlight SPC-15 Nose-To-Brain Technology At 2026 Nasal Innovation Forum(RTTNews) – Silo Pharma, Inc. (SILO) announced that company representatives will participate in the IPAC-RS 2026 Nasal Innovation Forum, scheduled for September 16-17, 2026, in Jersey City, New Jersey.
- RTTNews · Aug 19, 1:34 AM EDTSilo Strengthens IP Portfolio With Canadian Patent Allowance For PTSD Drug Candidate; Stock Down(RTTNews) – Silo Pharma (SILO), a developmental-stage biopharmaceutical company, announced that the Canadian Intellectual Property Office has issued a Notice of Allowance for a patent application covering its lead candidate, SPC-15.
- RTTNews · Aug 10, 11:49 AM EDTSilo Receives European Patent For Preventive PTSD Therapy SPC-15(RTTNews) – Silo Pharma, Inc. (SILO), a developmental-stage biopharmaceutical and an AI agent platform, on Monday announced that the European Patent Office (EPO) has granted a patent covering its lead candidate, SPC-15.
- RTTNews · Jul 15, 6:14 AM EDTSilo's QwikAgents Participates In AI Developer Program To Advance AI Platform(RTTNews) – Silo Pharma, Inc. (SILO), a biopharmaceutical company, announced its wholly owned subsidiary, QwikAgents has joined the Advanced Micro Devices' AI developer program to support the development of an artificial intelligence platform.
- RTTNews · Jul 10, 10:18 AM EDTSilo Pharma Announces Up To $11.7 Mln Private Placement; Stock Drops 22%(RTTNews) – Silo Pharma, Inc. (SILO), a biopharmaceutical company, Friday announced a definitive agreement for a private placement with potential gross proceeds of up to $11.7 million.
- RTTNews · Apr 23, 4:10 AM EDTSilo Pharma Expands Into AI Agent Market With Qwikagents Platform Acquisition; Stock Down(RTTNews) – Silo Pharma, Inc. (SILO), a developmental-stage biopharmaceutical and cryptocurrency treasury company, announced a strategic expansion into AI technology as a second line of business, following its recent purchase of Qwikagents.ai's assets, an AI platform designed to
- RTTNews · Apr 20, 8:14 AM EDTSilo Pharma To Advance SPC-15 As PTSD Treatment After U.S. Executive Order(RTTNews) – Silo Pharma Inc. (SILO), a developmental-stage biopharmaceutical company, on Monday announced plans to advance psychedelic-based therapies for treating mental health disorders, including SPC-15 in treating post-traumatic stress disorder, following an executive order b
- RTTNews · Apr 7, 2:56 AM EDTSilo Pharma Secures European Patent For Novel PTSD Prevention Therapy, Stock Up(RTTNews) – The European Patent Office has signaled its intent to grant Silo Pharma, Inc. (SILO) a patent covering a groundbreaking approach to preventing stress-related disorders, marking a significant milestone in the company's pipeline.
- RTTNews · Feb 24, 6:18 AM ESTSilo Pharma Announces $1 Mln Share Buyback Program; Stock Up(RTTNews) – Silo Pharma, Inc. (SILO), a development-stage biopharmaceutical company, announced that its board of directors has authorised a share repurchase program to acquire up to $1 million of the company's common stock.
- MarketBeat · Sep 9, 6:45 PM EDT3 Under-the-Radar Biotechs Under $5 That Could Soar 200%Investing in biotechnology stocks is typically reserved for speculative investors. For starters, many of these companies are clinical or pre-clinical stage companies. They’re not yet profitable, and many are even pre-revenue, meaning the long-term payoff will likely be years awa
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Silo Pharma, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.